Full-Time

Scientist, Computational Biology

Posted on 11/14/2025

Cell Signaling Technology

Cell Signaling Technology

1,001-5,000 employees

Antibody development and validated research tools

Compensation Overview

$118k - $144k/yr

Peabody, MA, USA

In Person

Category
Biology & Biotech (2)
,
Required Skills
Bash
Python
Data Science
R
Neural Networks
Machine Learning
Requirements
  • Ph.D. in Computational Biology, Bioinformatics, Data Science, Structural Biology, Immunology, or related field.
  • Proficiency in programming languages such as Python, R, and Bash.
  • Experience with bioinformatics tools for sequencing data, particularly B cell receptor sequencing and single-cell analysis.
  • Familiarity with applying machine learning methods to biological data.
  • Experience working in cloud computing and high-performance computing environments.
  • Strong problem-solving ability and effective communication skills for interdisciplinary collaboration.
Responsibilities
  • Develop and implement scalable bioinformatics workflows for B cell receptor sequencing, single-cell analysis, spatial biology, epigenetics, and multi-omics integration.
  • Apply rigorous standards for reproducibility and documentation.
  • Design and apply machine learning and deep learning models to large-scale biological and structural datasets.
  • Develop predictive methods for antibody-antigen interactions and protein structure analysis.
  • Apply structure prediction and molecular docking tools (e.g., AlphaFold, Rosetta, AutoDock) to model protein and antibody interactions.
  • Partner with Structural Biology, Proteomics, Molecular Biology, and Single Cell Technologies teams to support discovery initiatives.
  • Collaborate with immunologists, biologists, and data scientists to integrate computational results into CST’s R&D pipeline.
  • Contribute to cross-functional projects with Data Science, Software Engineering, and commercial stakeholders.
  • Communicate findings to technical and non-technical audiences through reports, presentations, and publications.
  • Share results and methods with internal and external collaborators.
  • Evaluate and implement emerging computational approaches, including AI/ML frameworks and structural modeling tools.
  • Recommend enhancements to CST’s bioinformatics infrastructure and practices.
Desired Qualifications
  • Demonstrated experience in structural prediction, molecular modeling, and antibody-antigen interaction analysis.
  • Knowledge of AI/ML applications in structural biology, antibody discovery, and protein design.
  • Hands-on experience with AlphaFold, Rosetta, molecular docking, or related structural modeling tools applied to biological or antibody–antigen systems.
  • Hands-on experience with proteomics analysis and multi-omics data integration.
  • Proficiency in software engineering best practices (version control, workflow automation, CI/CD).
  • Familiarity with containerization and orchestration technologies (e.g., Docker, Kubernetes) for scalable and reproducible computational analyses.
  • Knowledge of advanced data visualization methods for complex bioinformatics data.
  • Competencies in innovation, strategic problem solving, and collaborative teamwork.
Cell Signaling Technology

Cell Signaling Technology

View

Cell Signaling Technology (CST) provides antibodies and related research products for scientists, especially in cancer research. Its main offering is antibodies that are thoroughly validated for multiple experimental applications, ensuring reliability across experiments. CST’s antibodies are produced by Ph.D.-level scientists who also deliver technical guidance and support to researchers to help achieve dependable results. The company differentiates itself through its strong emphasis on validation, quality control, and hands-on scientific support from its own researchers, operating with a family-owned, research-institute mindset rather than purely as a generic supplier. CST’s goal is to help researchers obtain accurate, reproducible data by supplying validated antibodies and expert methods guidance for use in the lab.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Danvers, Massachusetts

Founded

1999

Simplify Jobs

Simplify's Take

What believers are saying

  • Cell signaling market grows to $7.11 billion by 2030 at 7.3% CAGR.
  • Bio-Techne adds Simple Western validation to CST antibodies in 2023.
  • CST invests $17.5M in Manchester property in July 2022 for expansion.

What critics are saying

  • Leveragen nanobodies displace CST monoclonal antibodies in 12-24 months.
  • Lunaphore scales single B cell screening, eroding CST revenue in 12-18 months.
  • Visiopharm dependency fails if Indica Labs captures market in 18-36 months.

What makes Cell Signaling Technology unique

  • CST launches SignalStar Multiplex IHC for 8-plex amplification in two days.
  • CST partners with Visiopharm to integrate SignalStar with Phenoplex software.
  • CST expands chimeric monoclonal antibodies to mouse, horse, and feline species.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Cell Signaling Technology who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Company Match

Tuition Reimbursement

Unlimited Paid Time Off

Parental Leave

Employee Assistance Program

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

-14%

1 year growth

-14%

2 year growth

-14%
BioSpace
Mar 26th, 2025
Leveragen Partners with Cell Signaling Technology to Advance Reagent Antibody Innovation with Proprietary Nanobody Technology

Leveragen partners with Cell Signaling Technology to advance reagent antibody innovation with proprietary nanobody Technology.

Cell Signaling Technology
Feb 12th, 2025
Does It Really Work? How InTraSeq(TM) Integrates Transcriptomic, Proteomic, & Intracellular Interaction Data

Cell Signaling Technology, Inc. is thrilled to announce the winners of the 5th annual Rising Black Scientists Awards!

Cell Signaling Technology
Oct 24th, 2023
Cell Signaling Technology and The Michael J. Fox Foundation Partner to Develop High-Quality Antibody Tools for Parkinson's Disease Research

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, announced their partnership with The Michael J. Fox Foundation for Parkinson's Research (MJFF) today to identify and develop high-quality monoclonal antibodies for promising Parkinson's disease (PD) targets.

Compsmag
Sep 20th, 2023
Green Chemistry Education: Cell Signaling Technology and Beyond Benign Join Forces for a Sustainable Future!

According to a recent announcement, Cell Signaling Technology (CST), a prominent life sciences discovery technology company, has partnered with Beyond Benign, a global green chemistry education nonprofit.

AZoNetwork
Sep 14th, 2023
Flexible Spatial Biology Solution for Up to 8-Plex Amplification in Two Days: CST Launches SignalStar™ Multiplex IHC

Cell Signaling Technology (CST) , a life science discovery technology company and leading provider of antibodies, kits, and services, today announced the launch of its SignalStar Multiplex IHC technology, a revolutionary new tool for spatial biology research using mid-plex, high-throughput immunohistochemistry (IHC) assays.

INACTIVE